halothane has been researched along with Neuromuscular Diseases in 10 studies
Neuromuscular Diseases: A general term encompassing lower MOTOR NEURON DISEASE; PERIPHERAL NERVOUS SYSTEM DISEASES; and certain MUSCULAR DISEASES. Manifestations include MUSCLE WEAKNESS; FASCICULATION; muscle ATROPHY; SPASM; MYOKYMIA; MUSCLE HYPERTONIA, myalgias, and MUSCLE HYPOTONIA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The association of malignant hyperthermia (MH) with neuromuscular disorders has been recognized since 1970." | 5.27 | Halothane-caffeine contracture testing in neuromuscular diseases. ( Fletcher, JE; Heiman-Patterson, TD; Rosenberg, H; Tahmoush, AJ, 1988) |
| "The association of malignant hyperthermia (MH) with neuromuscular disorders has been recognized since 1970." | 1.27 | Halothane-caffeine contracture testing in neuromuscular diseases. ( Fletcher, JE; Heiman-Patterson, TD; Rosenberg, H; Tahmoush, AJ, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (60.00) | 18.7374 |
| 1990's | 4 (40.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mortier, W | 2 |
| Biesel, C | 1 |
| Adnet, PJ | 1 |
| Krivosic-Horber, RM | 1 |
| Krivosic, I | 2 |
| Haudecoeur, G | 1 |
| Reyford, HG | 1 |
| Adamantidis, MM | 1 |
| Medahoui, H | 1 |
| Hopkins, PM | 1 |
| Ellis, FR | 1 |
| Halsall, PJ | 1 |
| Kafer, ER | 1 |
| Marsh, HM | 1 |
| Laws, I | 1 |
| Heytens, L | 1 |
| Martin, JJ | 1 |
| Van de Kelft, E | 1 |
| Bossaert, LL | 1 |
| Krivosic-Horber, R | 1 |
| Heiman-Patterson, TD | 1 |
| Rosenberg, H | 1 |
| Fletcher, JE | 1 |
| Tahmoush, AJ | 1 |
| Young, TM | 1 |
1 review available for halothane and Neuromuscular Diseases
| Article | Year |
|---|---|
Malignant hyperthermia: relation to other diseases.
Topics: Caffeine; Calcium Channels; Diagnosis, Differential; Halothane; Humans; Malignant Hyperthermia; Musc | 1990 |
9 other studies available for halothane and Neuromuscular Diseases
| Article | Year |
|---|---|
Pharmacological in-vitro studies in malignant hyperthermia in childhood.
Topics: Adolescent; Biopsy; Caffeine; Child; Child, Preschool; Dose-Response Relationship, Drug; Halothane; | 1982 |
Viability criterion of muscle bundles used in the in vitro contracture test in patients with neuromuscular diseases.
Topics: Caffeine; Disease Susceptibility; Halothane; Humans; In Vitro Techniques; Malignant Hyperthermia; Me | 1994 |
Comparison of in vitro contracture testing with ryanodine, halothane and caffeine in malignant hyperthermia and other neuromuscular disorders.
Topics: Caffeine; Disease Susceptibility; Dose-Response Relationship, Drug; Halothane; Humans; In Vitro Tech | 1993 |
The effects of anesthetic drugs and disease on the chemical regulation of ventilation.
Topics: Anesthetics; Anti-Anxiety Agents; Autonomic Nervous System; Barbiturates; Benzodiazepines; Carbon Di | 1977 |
Medical risks and dental anaesthetics.
Topics: Analgesics; Anesthesia, Dental; Anesthesia, General; Anesthesia, Local; Anti-Bacterial Agents; Antic | 1975 |
In vitro contracture tests in patients with various neuromuscular diseases.
Topics: Adolescent; Adult; Aged; Caffeine; Child; Child, Preschool; Disease Susceptibility; Drug Hypersensit | 1992 |
[Central core disease associated with malignant hyperthermia sensitivity].
Topics: Adolescent; Adult; Aged; Biopsy; Caffeine; Child; Child, Preschool; Creatine Kinase; Female; Halotha | 1989 |
Halothane-caffeine contracture testing in neuromuscular diseases.
Topics: Biopsy; Caffeine; Halothane; Humans; Malignant Hyperthermia; Muscle Contraction; Muscles; Neuromuscu | 1988 |
Anaesthesia for dental extraction: a comparison of various techniques in the author's hands.
Topics: Adult; Anesthesia, Dental; Anesthesia, Inhalation; Anesthesia, Intravenous; Cardiovascular Diseases; | 1974 |